Encompass Health dividend and valuation
$122.49Change from previous close: −1.76%Absolute change: −$2.20
Valuation
Encompass Health paid $0.78 per share in dividends over the last 12 months (yield 0.6%). Last ex-dividend date: October 1, 2026. The P/E ratio is 20.9. The average price target of 12 analysts is $148.17.
What would Encompass Health's dividends pay over 10 years? Work it out with the dividend calculator
Data as of October 7, 2026
Valuation multiples
- Market cap
- $12.3B
- Enterprise value
- $15.9B
- P/E (trailing 12 months)
- 20.9
- Forward P/E
- 18.7
- PEG
- 0.41
- Price/book
- 4.74
- Price/sales
- 1.98
- EV/EBITDA
- 10.9
- EV/revenue
- 2.56
Profitability and growth
- Gross margin
- 43.9%
- Operating margin
- 18.1%
- Net margin
- 10.0%
- ROE
- 25.0%
- ROA
- 9.8%
- ROIC
- 14.5%
- Revenue growth (year over year)
- 9.6%
- Earnings growth (year over year)
- 10.8%
Financial health
- Total cash
- $107.7M
- Total debt
- $2.84B
- Debt/equity
- 0.82
- Current ratio
- 1.19
- Quick ratio
- 0.91
- Altman Z-Score
- 3.32
- Piotroski F-Score
- 7.00
Dividends
- Annual dividend per share
- $0.78
- Dividend yield
- 0.6%
- Payout ratio
- 13.0%
- Ex-dividend date
- October 1, 2026
Analysts and estimates
- Average price target
- $148.17
- Median price target
- $150.00
- High price target
- $155.00
- Low price target
- $140.00
- Analysts with a price target
- 12
- Consensus
- Strong buy
- Forward EPS
- $6.68
- EPS estimate, current year
- $6.11
Shares and trading
- Beta
- 0.60
- Average volume
- 919.46K
- Shares outstanding
- 98.65M
- Float
- 97.65M
- Institutional ownership
- 100.9%
- Insider ownership
- 0.9%
- Short interest (% of float)
- 3.4%
- Short ratio (days)
- 3.73